medigraphic.com
ISSN 1561-302X (Print)

2021, Number 4

Next >>

Rev cubana med 2021; 60 (4)

Neurological complications due to COVID-19

Saavedra-Torres JS, Pinzón FMV, Zúñiga CLF, Salguero BC, Zamora BTO

Language: Spanish
References: 16
Page: 1-4
PDF size: 213.37 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients withcoronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020. DOI:https://doi.org/10.1001/jamaneurol.2020.1127

  2. Lechien JR, Chiesa-Estomba CM, De Siati DR. Olfactory and gustatorydysfunctions as a clinical presentation of mild-to-moderate forms of thecoronavirus disease (COVID-19): a multicenter European study. Eur ArchOtorhinolaryngol. 2020[acceso: 04/05/2020]. 277(8):2251-2261. Disponible en:https://pubmed.ncbi.nlm.nih.gov/32253535/

  3. Giacomelli A, Pezzati L, Conti F. Self-reported olfactory and taste disorders inSARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020. DOI:https://doi.org/10.1093/cid/ciaa330

  4. Moriguchi T, Harii N, Goto J. A first case of meningitis/encephalitis associatedwith SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-58.

  5. Beyrouti R, Adams ME, Benjamin L. Characteristics of ischaemic strokeassociated with COVID-19. J Neurol Neurosurg Psychiatry. 2020. DOI:https://doi.org/10.1136/jnnp-2020-323586

  6. Boehme AK, Ranawat P, Luna J, Kamel H, Elkind MS. Risk of acute stroke afterhospitalization for sepsis: a case-crossover study. Stroke. 2017;48:574-80.

  7. Aravinthan Varatharaj NT, Mark Ellul A, Nicholas W, Davies S, et al.Neurological and neuropsychiatric complications of COVID-19 in 153 patients: aUK-wide surveillance study. The Lancet Psychiatry. Elsevier- Date. 2020.

  8. The British Pediatric Neurology Association. Neurological complications ofCOVID-19. 2020[acceso: 04/05/2020]. Disponible en:https://bpna.org.uk/bpnsu/project.php?pid=4

  9. Solomon T, Michael BD, Smith PE. Management of suspected viral encephalitisin adults-Association of British Neurologists and British Infection AssociationNational Guidelines. J Infect. 2012;64:347-73.

  10. Liu K, Pan M, Xiao Z, Xu X. Neurological manifestations of the coronavirus(SARS-CoV-2) pandemic 2019-2020. J Neurol Neurosurg Psychiatry. 2020;91:669-70.

  11. Ellul MA, Varatharaj A, Nicholson T. Defining causality in COVID-19 andneurological disorders. J Neurol Neurosurg Psychiatry. 2020. DOI:https://doi.org/10.1136/jnnp-2020-323667

  12. González Pinto T, Luna Rodríguez A, Moreno Estébanez A, Aguirre Beitia G,Rodríguez Antigüedad A, Ruiz Lopez M. Emergency room neurology in times ofCOVID-19: malignant ischaemic stroke and SARS-CoV-2 infection. Eur J Neurol.2020. DOI: https://doi.org/10.1111/ene.14286

  13. Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ.Neuroinvasive and neurotropic human respiratory coronaviruses: potentialneurovirulent agents in humans. Adv Exp Med Biol. 2014;807:75-96.

  14. Morfopoulou S, Brown JR, Davies EG, Anderson G, Virasami A, Qasim W, et al.Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med.2016;375:497-8.

  15. Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus inthe central nervous system of a child with acute disseminated encephalomyelitis.Pediatrics 2004;113:e73-6.

  16. Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acuterespiratory syndrome. Acta Neurol Taiwan. 2005;14:113-9.




2020     |     www.medigraphic.com